Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Weight Loss 1Prostatic Neoplasms 1Hot Flashes 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Body Weight 1

Interventions

Megestrol Acetate 9Exercise 6Standard of Care 4Olanzapine 3Ibuprofen 3Blood Specimen Collection 3anamorelin 2Resistance Training 2Physical Therapy Modalities 2Nutrition Assessment 2Mirtazapine 2Melatonin 2Infliximab 2Dietary Supplements 2Diet Therapy 2Cyproheptadine 2testosterone enanthate 1remune 1ostarine 1olanzapine-fluoxetine combination 1nabiximols 1nabilone 1irinotecan sucrosofate 1fucoidan 1dermcidin 1clazakizumab 1bermekimab 1alkaloid GB18 1Vitamin D 1Sodium Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cachexia × Caseins × Clear all
NCT01046383 2015-01-21

Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients

Immunotec Inc.

Phase 3 Terminated
16 enrolled
Thoracic

Body Weight, Cachexia, Carcinoma, Non-Small-Cell Lung, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡